Tickers

1. Composite Trajectory Verdict

The income statement is the primary driver for assessing FEIM's performance given its contract-based manufacturing model where revenue recognition and margin trends reflect program execution and pricing power. The annual FY2026 results show significant deterioration in revenue, margins, and profitability, while the most recent quarter (Q1 FY2027) shows sharp improvement across all income statement metrics and a transformed balance sheet from a $58M equity raise. Prior quarters (Q3 FY2026) also showed deterioration. This divergence between annual and latest quarterly trends, combined with the one-time nature of the equity infusion, results in a mixed trajectory.

Composite Trajectory: Mixed

2. Red Flags

• Annual revenue declined 9.4% to $63.2M (10-K FY2026, Consolidated Statements of Operations) while gross margin fell 14 percentage points to 29.1% (10-K FY2026, MD&A).
• Operating income swung from $11.7M profit to $3.0M loss (10-K FY2026, Consolidated Statements of Operations).
• Net income fell from $23.7M to -$0.9M, driven partly by a $11.5M tax benefit in FY2025 from a valuation allowance release that did not recur (10-K FY2026, Note 12).
• Inventory reserves remain high at $10.0M (44% of gross inventory) at April 30, 2026 (10-K FY2026, Note 4).
• Contract liabilities (deferred revenue) decreased 31% to $9.4M, indicating lower advance billings (10-K FY2026, Consolidated Balance Sheets).
• FY2025 included a $9.6M special dividend (10-K FY2026, MD&A Liquidity) while FY2026 used cash for treasury stock ($1.6M) and capex ($2.9M), reducing cash to $1.6M from $4.7M (10-K FY2026, Consolidated Statements of Cash Flows).
• Customer concentration: 91% of sales to U.S. Government in FY2026 (10-K FY2026, Note 13).
• Goodwill written off entirely ($0.4M) due to FEI-Elcom restructuring (10-K FY2026, Note 1).
• The $3.8M inventory write-down from FEI-Elcom restructuring flowed through cost of revenues, depressing gross margin (10-K FY2026, MD&A Gross Profit).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Annual FY2026 results deteriorated sharply versus FY2025: revenue fell 9.4% to $63.2M, gross margin compressed from 43.1% to 29.1%, operating income swung from $11.7M profit to $3.0M loss, and net income fell from $23.7M to -$0.9M (10-K FY2026, Consolidated Statements of Operations). However, the most recent quarter (Q1 FY2027 ended July 31, 2026) shows strong improvement: revenue surged 69.8% to $23.5M, gross margin expanded to 45.8% from 36.8%, operating income jumped to $5.2M from $0.4M, and net income rose to $4.2M from $0.6M (10-Q Q1 FY2027, Condensed Consolidated Statements of Operations). The intervening quarter (Q3 FY2026 ended Jan 31, 2026) showed continued deterioration with revenue down 10.8% and operating margin of 7.5% versus 18.3% a year prior (10-Q Q3 FY2026, MD&A). The divergence between the full-year decline and the latest quarter's strength, driven partly by satellite and non-space government revenue growth, yields a mixed earnings trajectory.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Annual operating cash flow improved to $1.3M in FY2026 from -$1.4M in FY2025 (10-K FY2026, Consolidated Statements of Cash Flows), but capital expenditures rose to $2.9M from $1.8M, leaving free cash flow negative in both years (-$1.6M vs -$3.2M). Cash and restricted cash declined to $2.9M at April 30, 2026 from $6.1M a year earlier (10-K FY2026, Consolidated Statements of Cash Flows). In contrast, Q1 FY2027 operating cash flow increased to $2.6M from $1.2M in Q1 FY2026 (10-Q Q1 FY2027, Condensed Consolidated Statements of Cash Flows), and a $58.1M equity offering (net) transformed the cash position to $62.7M at July 31, 2026 (10-Q Q1 FY2027, Condensed Consolidated Balance Sheets). The annual trend shows modest operational improvement but declining cash reserves, while the latest quarter reflects a one-time financing event that dominates the cash trajectory.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: At April 30, 2026 versus April 30, 2025, total assets decreased slightly to $90.7M from $93.7M, current assets fell to $48.0M from $53.1M, cash dropped to $1.6M from $4.7M, and working capital declined to $27.0M from $29.7M (10-K FY2026, MD&A and Consolidated Balance Sheets). The current ratio remained 2.3x. Stockholders' equity rose modestly to $56.4M from $55.6M, with retained earnings falling to $2.8M from $3.7M. By July 31, 2026, after the public offering, the balance sheet strengthened dramatically: total assets $153.6M, cash $61.4M, equity $119.8M, and current ratio 5.3x (10-Q Q1 FY2027, Condensed Consolidated Balance Sheets). The annual comparison shows gradual erosion of liquidity and working capital, while the quarter-end snapshot reflects a discrete capital raise that masks the underlying trend.

6. Data Gaps

• Full quarterly income statements, cash flows, and balance sheets for Q2 FY2026 (three months ended October 31, 2025) and Q1 FY2025 (three months ended July 31, 2024) to complete a four-quarter trend.
• Nine-month cash flow and balance sheet data for the period ended January 31, 2026 (only income statement percentages provided in 10-Q Q3 FY2026 MD&A).
• Segment-level cash flow statements for FEI-NY and FEI-Zyfer.
• Detailed breakdown of the $3.1M increase in SG&A in FY2026 (Colorado facility, restructuring, sick/PTO policy change, legal) beyond the narrative description.
• Backlog composition and historical conversion rates to revenue to assess revenue visibility.
• Comparative figures for Q1 FY2025 (July 31, 2024) to compute YoY growth for the quarter ended July 31, 2025 (only available as prior year in Q1 FY2027 filing).